Hemab Therapeutics prices IPO at $18 per share - Investing.com
Hemab Therapeutics prices IPO at $18 per share Investing.com
ORIGINAL SOURCE →via IPO News (GN)
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · finance
- [FINANCE] [Editorial] Creating a smoke-free generation
- [FINANCE] After 25 years of negotiation, the Mercosur-EU agreement takes effect this Friday
- [FINANCE] Police fire at stolen car after checkpoint breach in West Bank
- [FINANCE] The Outrage Machine reloaded
- [FINANCE] Veeva Systems climbs 9% after S&P 500 addition
- [FINANCE] Getting prediction market regulation right - a16z crypto